INDACO BIO
Indaco Bio Fund invests in the development of innovative pharmacological therapies. All therapeutic indications are covered, with particular attention to Oncology, CNS, Ophthalmology, Metabolic diseases, Virology and Infectious diseases.
Investments are focused on the Italian Biotech sector with select investments in other European countries, USA, Canada or Israel.
2022
Start Date
2032
Fund Term
€97M
AUM (first closing)
TEAM
Davide Turco
Co-Founder
Managing Director
Managing Director
Elizabeth Robinson
Co-Founder
Vice Chairman
Vice Chairman
Giovanni Rizzo
Partner Indaco BIO Fund
Goncalo Rebelo De Andrade
Partner Indaco BIO Fund
Lukas Hill
Associate
COLLABORATIONS
Advisor: Biotech Venture Advisors S.r.l.
Indaco Bio Fund Investment Committee is supported by Biotech Venture Advisors S.r.l. which is made of highly professionals with scientific background and Biotech track record advising on the investment opportunities and supporting the Portfolio Companies.
Advisor Team
Giovanni Rizzo
Partner Indaco BIO Fund & CEO Biotech Venture Advisors S.r.l.
Goncalo Rebelo De Andrade
Partner Indaco BIO Fund
Elena Beltrami
Associate at BVA
Vittoria Pavoncello
Analyst at BVA
